Although the virological features of serologically silent hepadnaviral primary occult infection (POI) have been relatively well recognized in the woodchuck model of hepatitis B virus infection, the characteristics of accompanying immune responses remain unknown. In this study, the kinetics of woodchuck hepatitis virus (WHV)-specific and generalized (mitogen-induced) T-cell proliferative responses and cytokine expression profiles in circulating lymphoid cells and the liver, along with WHV-specific antibody responses, were investigated during experimentally induced POI and subsequent challenge with a liver-pathogenic dose (>10 3 virions) or liver-nonpathogenic dose (50 virions) of the same virus. The data revealed that POI, which does not prompt WHV surface antigenemia, antiviral antibody response, and hepatitis or protect from challenge with a liver-pathogenic virus dose, was accompanied by the appearance of a strong WHV-specific T-cell response directed against multiple viral epitopes that intermittently persisted at low levels for up to 10-months during follow-up. Furthermore, immediately after exposure to a liver-nonpathogenic dose of WHV, lymphocytes acquired a heightened capacity to proliferate in response to mitogenic stimuli and displayed augmented expression of alpha interferon, interleukin-12 (IL-12), and IL-2, but not tumor necrosis factor alpha. Overall, the kinetics of WHV-specific and mitogen-induced T-cell proliferative and cytokine responses in POI were closely comparable to those seen in infection induced by liver-pathogenic viral doses. The data demonstrated that virus-specific T-cell proliferative reactivity is a very sensitive indicator of exposure to hepadnavirus, even to small amounts inducing serologically mute infection. They also showed that hepadnaviral POI is not only a molecularly but also an immunologically identifiable and distinctive entity.Hepatitis B virus (HBV) is a noncytopathic virus causing an infection having several distinctive clinical profiles ranging from acute hepatitis (AH) or chronic hepatitis (CH) to a serologically undetectable, seemingly asymptomatic infection, called an occult HBV infection (OBI) (67). Following exposure to HBV, more than 90% of immunocompetent adults developing AH resolve liver inflammation (4, 17), but they fail to eradicate the virus completely and persistent occult infection seems to invariably follow (52,57,67,68,77). The remaining ϳ10% of individuals develop CH, which is diagnosed when detection of hepatitis B surface antigen (HBsAg) in serum and biochemical and histological indicators of liver inflammation protract for more than 6 months. This form of hepatitis frequently advances to cirrhosis and hepatocellular carcinoma (HCC) (4, 9).In the last decade, it became apparent that HBV replication commonly persists at low levels after resolution of AH in the context of apparent absence of clinical symptoms. It is also expected that this form of HBV infection could be a consequence of resolution of a clinically asymptomatic, but serologically tran...